Central Serous Chorioretinopathy: Quick Answers to the Most Frequently Asked Questions
In a quick-fire Q&A session, the head of the Department of Laser Microsurgery for Eye Diseases at the “SI V.P. Filatov Institute of Eye Diseases and Tissue Therapy of the NAMS of Ukraine”, Ilya Olegovich Nassinnyk — Candidate of Medical Sciences, Senior Research Fellow, and ophthalmologist of the highest category.
Central serous chorioretinopathy (CSC) is a retinal disorder that most commonly affects young adults and is frequently associated with psychological or emotional stress. Due to its characteristic clinical profile, it has even been referred to as the "disease of young businessmen."
One of the earliest manifestations of the disease is the appearance of a semi-transparent spot (central scotoma) in the central visual field. Patients may also experience metamorphopsia (distortion of objects) and describe their vision as if looking through thin parchment or a transparent film. The central part of the image becomes blurred, indistinct, and in some cases markedly distorted.
Although central serous chorioretinopathy was previously diagnosed predominantly in men, however, today the condition affects both men and women.
The specialist emphasises that patients should not attempt to diagnose themselves, even with the assistance of modern digital services or artificial intelligence. Any change in vision should prompt an examination by an ophthalmologist to ensure an accurate diagnosis based on a comprehensive ophthalmic examination.
In central serous chorioretinopathy, impaired retinal trophic support results in the accumulation of subretinal fluid, leading to localised serous detachment of the neurosensory retina. These pathological changes are responsible for the characteristic impairment of central vision.
Symptoms may occur at any time,however, the disease most commonly develops in young adults, often following significant psycho-emotional stress.
To establish the diagnosis, the ophthalmologist performs a comprehensive ophthalmic examination, including best-corrected visual acuity assessment, fundus examination, optical coherence tomography (OCT), and, in selected cases, fluorescein angiography (FA).
Even after improvement, patients should continue to undergo regular follow-up examinations. Central serous chorioretinopathy is a chronic, recurrent disease, and the risk of recurrence persists even after stabilization of the condition has stabilised.
Timely consultation with an ophthalmologist and adherence to the prescribed treatment and follow-up recommendations allow early diagnosis, appropriate monitoring of disease progression, and reduction of the risk of recurrent to be reduced.
